Lesaka Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LSAK research report →
Range $7.56 – $7.56
Price Chart
About the company
Lesaka Technologies, Inc. is a prominent financial technology firm specializing in delivering essential fintech solutions to individuals and small businesses who are either unbanked or underbanked. While its primary focus is on South Africa, the company also serves international markets.
- CEO
- Lincoln Camagu Mali
- IPO
- 1999
- Employees
- 3,861
- HQ
- Johannesburg, GT, ZA
Get TickerSpark's AI analysis on LSAK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $271.73M
- P/E
- 76.80
- Fwd P/E
- 7.30
- PEG
- 0.23
- P/S
- 0.35
- P/B
- 1.08
- EV/EBITDA
- 2.08
- Div Yield
- 0.00%
- Gross Margin
- 25.98%
- Op Margin
- 2.36%
- Net Margin
- 0.42%
- ROE
- 1.20%
- ROIC
- 2.17%
Latest fiscal year · YoY change
- Revenue
- $721.55M+9.4%
- Gross Profit
- $183.37M+5.9%
- Op Income
- $18.61M
- Net Income
- $2.76M+103.2%
- EPS
- $0.04+103.1%
- OCF Growth
- +675.0%
- FCF Growth
- +220.8%
- 52W High
- $5.54
- 52W Low
- $2.75
- 50D MA
- $4.09
- 200D MA
- $4.60
- Beta
- 0.33
- RSI (14)
- 33
- Avg Volume
- 194.09K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Lesaka said Q1 FY2027 met guidance, with consumer and enterprise strong, while merchant was a low point before an expected second-half recovery.· November 5, 2026
- Q1 met guidance on all three measures for the 17th straight quarter of profitability guidance delivery.
- Net revenue rose 8% to ZAR 1.58 billion; group Adjusted EBITDA was ZAR 220 million and adjusted EPS was ZAR 0.72.
- Consumer and enterprise posted strong growth, while merchant EBITDA fell sharply because of exceptional items, restructuring, and margin pressure.
- Management expects merchant to rebound from Q2, with EBITDA above ZAR 130 million next quarter and a record merchant quarter in Q4.
- Full-year guidance was reiterated, and management still expects Bank Zero to complete by end-January 2027 if not earlier.
Net revenue increased 8% to ZAR 1.58 billion. Group Adjusted EBITDA was ZAR 220 million, and adjusted earnings were ZAR 60 million or ZAR 0.72 per share. Year over year, EBITDA fell 17% and adjusted EPS fell 26%. Consumer net revenue increased 24% to ZAR 668 million, enterprise net revenue rose 19% to ZAR 263 million, and merchant net revenue declined 7% to ZAR 675 million; merchant EBITDA fell to ZAR 77 million from ZAR 158 million, consumer EBITDA rose 38% to ZAR 206 million, and enterprise EBITDA rose 28% to ZAR 29 million. Guidance for Q2 FY2027 is net revenue of ZAR 1.62 billion-ZAR 1.72 billion, group Adjusted EBITDA of ZAR 280 million-ZAR 320 million, and adjusted EPS of ZAR 1-ZAR 1.40. Full-year guidance is net revenue of ZAR 7 billion-ZAR 7.7 billion, group Adjusted EBITDA of ZAR 1.45 billion-ZAR 1.6 billion, and adjusted EPS of ZAR 7.50-ZAR 8.50, inclusive of Bank Zero.
Ali Mazanderani framed the quarter as evidence that the company is tracking to its longer-term plan, saying Lesaka met guidance and continues to build momentum in consumer and enterprise. He emphasized that consumer has proven product-market fit, enterprise has become a meaningful profit contributor, and merchant is in a turnaround phase that should improve as new strategy, cost actions, and volumes flow through. His tone was confident and forward-looking, especially on the three-year ambition for more than 20% net revenue CAGR, more than 30% Adjusted EBITDA CAGR, and more than 40% adjusted EPS CAGR.
Dan Smith focused on the financial inflection point and the near-term funding and cost profile. He cited ZAR 1.58 billion of net revenue, ZAR 220 million of group Adjusted EBITDA, and ZAR 60 million of adjusted earnings, while noting cash generated from operations of ZAR 245 million before working capital, loan book funding, tax, and interest. He highlighted ZAR 253 million invested in lending books, ZAR 148 million of capex in the quarter, net debt rising to ZAR 2.73 billion, and leverage moving from 1.9x-2.2x, with a temporary rise to around 3x expected in Q2; he also reiterated FY2027 capex guidance of ZAR 550 million total, including ZAR 450 million operational capex and ZAR 100 million office spend.
Analysts pressed on merchant recovery timing, merchant lending arrears/provisioning, and the consumer pricing change on the new nine-month ZAR 5,000 loan. Management said merchant EBITDA should exceed ZAR 130 million in Q2 and that Q4 should be the best-ever merchant quarter, with margins initially reverting to north of 20%; they also said merchant lending is still early and that provisioning was tightened, with roughly 85% of the merchant book performing. On consumer pricing, they said the increase from 12% to 15% applies only to the ZAR 5,000 nine-month loan after a modest uptick in risk. Questions also focused on Bank Zero timing and merchant competition, where management said the deal is still expected to close by the long-stop date, but if needed they would address an extension later; they added that as an insurgent in merchant, Lesaka can offer wholesalers a more attractive deal without cannibalizing existing revenue.
The call showed strong momentum in consumer and enterprise, with both segments growing double digits and consumer lending, insurance, and cross-sell all expanding. Management was explicit that merchant should improve materially from Q2 onward as restructuring costs fade, community monetization improves, and Bank Zero later lowers funding costs.
Merchant remains the main pressure point, with EBITDA down sharply in Q1 due to restructuring, duplicated costs, lower revenue, and margin pressure, and management acknowledged corporate growth may not resume until FY2028. Cash generation is also under pressure from lending growth and capex, net debt increased to ZAR 2.73 billion, and leverage is expected to rise temporarily in Q2 before Bank Zero benefits arrive.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 63.3%
- Shares Outstanding
- 86.54M
- Float Shares
- 54.80M
of shares held by institutions
45 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 5.11M | ▼ 22.50K |
| Goldman Sachs Group Inc | 5.04M | ▼ 12.73K |
| Rathbones Group PLC | 3.66M | 0 |
| Kingsway Capital Partners Ltd | 1.64M | ▲ 717.14K |
| Potomac Capital Management, Inc. | 1.52M | ▲ 1.40K |
| Deutsche Bank AG\ | 439.31K | 0 |
| Citadel Advisors LLC | 234.59K | ▼ 165.82K |
| Ubs Group AG | 228.16K | ▼ 7.46K |
| Intrepid Family Office LLC | 200.00K | ▼ 50.00K |
| Marshall Wace, Llp | 197.51K | ▲ 68.06K |
| Renaissance Technologies LLC | 188.00K | ▲ 19.90K |
| Barclays PLC | 155.79K | ▼ 94.56K |
Held by 2 ETFs
Biggest fund positions in LSAK by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 26 | Mali Lincoln Camagu | sell | 55,093 |
| Nov 17, 26 | Kola Naeem Ebrahim | sell | 56,250 |
| Nov 17, 26 | Smith Daniel Luke | buy | 7,000 |
| Aug 3, 26 | Mazanderani Ali | other | 1,000,000 |
| Sep 28, 26 | Oates James Patrick | other | 0 |
| Sep 28, 26 | Lacerda Maria Carolina | other | 0 |
| Dec 1, 25 | Kola Naeem Ebrahim | sell | 68,319 |
| Sep 16, 26 | Mazanderani Ali | buy | 14,774 |
| Sep 15, 26 | Mazanderani Ali | buy | 28,226 |
| Apr 14, 26 | International Finance Corp | sell | 106,948 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LSAK coverage
Recent articles, reports, and earnings notes.
No research on LSAK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LSAK report →Lesaka Technologies, Inc. (LSAK) Q1 2027 Earnings Call Transcript
seekingalpha.com · Nov 7
Lesaka Technologies Q1 Earnings Call Highlights
marketbeat.com · Nov 6
Lesaka Technologies (LSAK) Q1 Earnings Top Estimates
zacks.com · Nov 4
Lesaka Delivers Q1 FY2027 Results in Line with Expectations, Reaffirms FY2027 Guidance
globenewswire.com · Nov 4
Financial Review: Lesaka Technologies (NASDAQ:LSAK) & Usio (NASDAQ:USIO)
defenseworld.net · Nov 3
Lesaka Webcast and Conference Call to Review First Quarter 2027 Results
globenewswire.com · Oct 20
Lesaka Technologies, Inc. (LSAK) Q4 2026 Earnings Call Transcript
seekingalpha.com · Sep 10
Lesaka Technologies Q4 Earnings Call Highlights
marketbeat.com · Sep 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.